Autologous DC therapy
Idiopathic Pulmonary Fibrosis · Dendritic Cell Immunotherapy
Clinical trials
1
Mechanism
Dendritic Cell Immunotherapy
Developer
German University Hospitals
Overview
Autologous DC therapy is an agent tracked by PF-Atlas in the context of idiopathic pulmonary fibrosis, acting via dendritic cell immunotherapy. It appears in 1 tracked IPF clinical trial.
Autologous DC therapy clinical trials
Explore related
Medical disclaimer. This page summarizes research about Autologous DC therapy for information only. It is not medical advice. Verify approval status and evidence with the FDA and a pulmonologist.